Novel Mechanism Drives Osteosarcoma
This is a Osteosarcoma news story, published by ScienceDaily, that relates primarily to LOH news.
Osteosarcoma news
For more Osteosarcoma news, you can click here:
more Osteosarcoma newsbiology news
For more biology news, you can click here:
more biology newsScienceDaily news
For more news from ScienceDaily, you can click here:
more news from ScienceDailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
osteosarcoma progression. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest osteosarcoma tumours news, aggressive bone cancer news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
osteosarcoma cancer cellsScienceDaily
•Researchers uncover what drives aggressive bone cancer
79% Informative
Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20 .
New research solves the mystery of what drives the genomic rearrangements causing the aggressive development and evolution of bone cancer tumours.
The study also presents a prognostic biomarker -- a biological characteristic of cancer cells that can help predict patient outcome -- that might be used to anticipate the likely course of the disease.
The finding has significant implications for the treatment of diverse cancer types.
Loss of heterozygosity ( LOH ) occurs when one copy of a genomic region is lost.
In osteosarcoma , a high degree of LOH across the genome predicts a lower survival probability.
LOH could help identify patients who are unlikely to benefit from treatment which can have very unpleasant effects.
VR Score
89
Informative language
98
Neutral language
27
Article tone
formal
Language
English
Language complexity
79
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links